FindTrial
Sign In

Ashwagandha kshirpaka on female infertility

Ashwagandha kshirpaka for management of vandhyatva with special referance to folliculogenesis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/07/020108
Enrollment
30
Registered
2019-07-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N970- Female infertility associated withanovulation

Interventions

Intervention1: Ashwagandha Kshirpaka: Freshly prepared Ashwagandha Kshirpaka 100ml once a day (before breakfast) from fifth day of menses for twelve days. Control Intervention1: Clomiphene Citrate: C

Sponsors

DrBinal Vijay Kolekar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Known patient with infertility with anovulatory cycles. Age group of patient between 18-40 years female. Patient who are having regular or irregular menstrual history. PCOS

Exclusion criteria

Exclusion criteria: ï?? Congenital absence or deformities of Uterus& ovaries. Patient having Ovarian tumour. Cancer of Cervix or Uterus. Known cases of Hypothyroid and Hyper thyroid patients. Known cases of Diabetes mellitus.

Design outcomes

Primary

MeasureTime frame
There is significant effect of Ashwagandha Kshirpaka in folliculogenesis with special reference to Vandhyatva.Timepoint: patient will be followed up once a month for 3 subsequent months.—

Secondary

MeasureTime frame
There is no significant effect of Ashwagandha Kshirpaka in folliculogenesis then clomiphen citrate.Timepoint: patient will be followed up once a month for 3 subsequent months.—

Countries

India

Contacts

Public ContactDr Mangesh Patil

Ymt ayurvedic medical college and hospital

drmangeshpatil21@gmail.com9320380219

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026